Targeting PLD1 alone or in combination with TMZ attenuated GBM tumorigenicity through microRNA (miR)‐320a and miR‐4496‐mediated downregulation of TMZ resistance factors, including MGMT. This evidence concerns the gene MGMT and glioblastoma.